Early-onset Alzheimer Disease and Its Variants.
Mendez MF.
Continuum (Minneap Minn). 2019 Feb;25(1):34-51. doi: 10.1212/CON.0000000000000687.
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA.
Science. 1993 Aug 13;261(5123):921-3. doi: 10.1126/science.8346443.
Risk factors for Alzheimer's disease.
A Armstrong R.
Folia Neuropathol. 2019;57(2):87-105. doi: 10.5114/fn.2019.85929.
Animal models of Alzheimer's disease: Applications, evaluation, and perspectives.
Chen ZY, Zhang Y.
Zool Res. 2022 Nov 18;43(6):1026-1040. doi: 10.24272/j.issn.2095-8137.2022.289.
An overview of the genes and biomarkers in Alzheimer's disease.
Krishnamurthy HK, Jayaraman V, Krishna K, Wang T, Bei K, Changalath C, Rajasekaran JJ.
Ageing Res Rev. 2025 Feb;104:102599. doi: 10.1016/j.arr.2024.102599. Epub 2024 Nov 28.
Genetics of familial and sporadic Alzheimer's disease.
Piaceri I, Nacmias B, Sorbi S.
Front Biosci (Elite Ed). 2013 Jan 1;5(1):167-77. doi: 10.2741/e605.
TREM2 - a key player in microglial biology and Alzheimer disease.
Ulland TK, Colonna M.
Nat Rev Neurol. 2018 Nov;14(11):667-675. doi: 10.1038/s41582-018-0072-1.
The Role of BMI1 in Late-Onset Sporadic Alzheimer's Disease.
Hogan R, Flamier A, Nardini E, Bernier G.
Genes (Basel). 2020 Jul 21;11(7):825. doi: 10.3390/genes11070825.
Cannabinoids in late-onset Alzheimer's disease.
Ahmed A, van der Marck MA, van den Elsen G, Olde Rikkert M.
Clin Pharmacol Ther. 2015 Jun;97(6):597-606. doi: 10.1002/cpt.117. Epub 2015 Apr 17.
A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.
Atwood CS, Bowen RL.
J Alzheimers Dis. 2015;47(1):33-47. doi: 10.3233/JAD-143210.
